Baxter International, Inc. Pump Recall Gets FDA's Highest-Risk Label Following 9 Severe Injuries

Published: May 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Baxter's infusion pump recall is associated with 9 severe adverse events and more than 3,500 complaints, getting the FDA's attention and highest-risk warning label. Medtech maker Baxter (NYSE:BAX) got the FDA's highest-risk warning after recalling a series of infusion pumps due to a software issue that could lead the devices to malfunction. The recall affects 2 models of Sigma Spectrum Infusion Pumps pumps, manufactured from July 1, 2005, through January 15, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news